Emergence of increasing linezolid-resistance in enterococci in a post-outbreak situation with vancomycin-resistant Enterococcus faecium

被引:29
作者
Schulte, B. [1 ]
Heininger, A. [2 ]
Autenrieth, I. B. [1 ]
Wolz, C. [1 ]
机构
[1] Univ Tubingen, Inst Med Mikrobiol & Hyg, D-72076 Tubingen, Germany
[2] Univ Tubingen, Klin Anasthesiol & Intens Med, D-72076 Tubingen, Germany
关键词
D O I
10.1017/S0950268807009508
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
During 2004 and at the start of 2005 a university hospital in Southwest Germany was affected by an extensive outbreak of vancomycin-resistant Enterococcus faecium (VRE). Although the outbreak was contained, linezolid-resistant enterococci emerged during and after the outbreak as the usage of linezolid became more common. Linezolid resistance was no longer limited to VRE. Nosocomial spread of linezolid-resistant but vancomycin-susceptible E. faecium was detected and these strains also emerged in patients without prior drug exposure. Linezolid should therefore be used with caution and the susceptibility of isolates monitored over time. Isolation precautions and screening of contacts should be considered to avoid spread of resistant isolates.
引用
收藏
页码:1131 / 1133
页数:3
相关论文
共 14 条
[1]   Emergence of linezolid resistance in Enterococcus faecium not dependent on linezolid treatment [J].
Bonora, MG ;
Ligozzi, M ;
Luzzani, A ;
Solbiati, M ;
Stepan, E ;
Fontana, R .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2006, 25 (03) :197-198
[2]   Discrimination between epidemic and non-epidemic glycopeptide-resistant E. faecium in a post-outbreak situation [J].
Borgmann, S. ;
Schulte, B. ;
Wolz, C. ;
Gruber, H. ;
Werner, G. ;
Goerke, C. ;
Klare, I. ;
Beyser, K. ;
Heeg, P. ;
Autenrieth, I. B. .
JOURNAL OF HOSPITAL INFECTION, 2007, 67 (01) :49-55
[3]   Surveillance of linezolid resistance in Germany, 2001-2002 [J].
Brauers, J ;
Kresken, M ;
Hafner, D ;
Shah, PM .
CLINICAL MICROBIOLOGY AND INFECTION, 2005, 11 (01) :39-46
[4]   Nosocomial spread of Enterococcus faecium resistant to vancomycin and linezolid in a tertiary care medical center [J].
Dobbs, Thomas E. ;
Patel, Mukesh ;
Waites, Ken B. ;
Moser, Stephen A. ;
Stamm, Alan A. ;
Hoesley, Craig J. .
JOURNAL OF CLINICAL MICROBIOLOGY, 2006, 44 (09) :3368-3370
[5]   Infections due to vancomycin-resistant Enterococcus faecium resistant to linezolid [J].
Gonzales, RD ;
Schreckenberger, PC ;
Graham, MB ;
Kelkar, S ;
DenBesten, K ;
Quinn, JP .
LANCET, 2001, 357 (9263) :1179-1179
[6]   Nosocomial spread of linezolid-resistant, vancomycin-resistant enterococcus faecium [J].
Herrero, IA ;
Issa, NC ;
Patel, R .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (11) :867-869
[7]   Linezolid-resistant Enterococcus faecium isolated from a patient without prior exposure to an oxazolidinone:: Report from the SENTRY Antimicrobial Surveillance Program [J].
Jones, RN ;
Della-Latta, P ;
Lee, LV ;
Biedenbach, DJ .
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2002, 42 (02) :137-139
[8]   Gene dosage and linezolid resistance in Enterococcus faecium and Enterococcus faecalis [J].
Marshall, SH ;
Donskey, CJ ;
Hutton-Thomas, R ;
Salata, RA ;
Rice, LB .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (10) :3334-3336
[9]   Antimicrobial resistance to linezolid [J].
Meka, VG ;
Gold, HS .
CLINICAL INFECTIOUS DISEASES, 2004, 39 (07) :1010-1015
[10]   Risk factors associated with the development of infection with linezolid- and vancomycin-resistant Enterococcus faecium [J].
Pai, MP ;
Rodvold, KA ;
Schreckenberger, PC ;
Gonzales, RD ;
Petrolatti, JM ;
Quinn, JP .
CLINICAL INFECTIOUS DISEASES, 2002, 35 (10) :1269-1272